0001567619-18-003090.txt : 20180925 0001567619-18-003090.hdr.sgml : 20180925 20180925160606 ACCESSION NUMBER: 0001567619-18-003090 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180924 FILED AS OF DATE: 20180925 DATE AS OF CHANGE: 20180925 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Karas Kevin R CENTRAL INDEX KEY: 0001522907 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35929 FILM NUMBER: 181085781 MAIL ADDRESS: STREET 1: C/O NATIONAL RESEARCH CORPORATION STREET 2: 1245 Q STREET CITY: LINCOLN STATE: NE ZIP: 68508 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NATIONAL RESEARCH CORP CENTRAL INDEX KEY: 0000070487 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 470634000 STATE OF INCORPORATION: WI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1245 Q STREET CITY: LINCOLN STATE: NE ZIP: 68508 BUSINESS PHONE: 4024752525 MAIL ADDRESS: STREET 1: 1245 Q STREET CITY: LINCOLN STATE: NE ZIP: 68508 4 1 doc1.xml FORM 4 X0306 4 2018-09-24 0 0000070487 NATIONAL RESEARCH CORP NRC 0001522907 Karas Kevin R C/O NATIONAL RESEARCH CORPORATION 1245 "Q" STREET LINCOLN NE 68508 0 1 0 0 SVP Finance, CFO, Treas & Secy Common Stock 2018-09-18 4 S 0 4065 39.7108 D 16051 D Common Stock 2018-09-19 4 S 0 735 38.5218 D 15316 D Employee Stock Option (right to buy) 10.75 2022-01-05 Common Stock 26403 26403 D Employee Stock Option (right to buy) 14.50 2023-01-07 Common Stock 20088 20088 D Employee Stock Option (right to buy) 18.80 2024-01-07 Common Stock 5334 5334 D Employee Stock Option (right to buy) 13.17 2025-01-06 Common Stock 19313 19313 D Employee Stock Option (right to buy) 15.23 2026-01-05 Common Stock 20458 20458 D Employee Stock Option (right to buy) 18.8 2027-01-04 Common Stock 16728 16728 D Employee Stock Option (right to buy) 36.8 2028-01-03 Common Stock 11617 11617 D The price in Column 4 is a weighted average price. The prices actually received ranged from $39.50 to $39.90. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. The price in Column 4 is a weighted average price. The prices actually received ranged from $38.50 to $38.55. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. This option became fully exercisable on January 5, 2017. This option became fully exercisable on January 7, 2018. This option becomes fully exercisable on January 7, 2019. This option becomes fully exercisable on January 6, 2020. This option becomes fully exercisable on January 5, 2021. This option becomes fully exercisable on January 4, 2022. This option becomes fully exercisable on January 3, 2023. /s/ Russell E. Ryba, Attorney-In-Fact for Kevin R. Karas 2018-09-19